Logo

molecular profiling

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Using a single-cell sequencing and clonal fitness mapping method, researchers compared EGFR-mutant lung cancer cell responses to EGFR inhibition or targeted protein degradation.

Natera Revenues Grow 35 Percent in Q4

The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million.

4HF Biotec Banking on Multiomic Data Analysis to Help Pharma Find New Oncology Compounds
Premium

German bioinformatics startup 4HF Biotec targets early-stage biotech development with technology to predict drug sensitivity based on tumor genetic profiles.

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.

BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research

The partners will apply whole-exome and whole-transcriptome analysis to evaluate two existing drugs for squamous cell carcinoma treatment.

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

Jun 15, 2020

Roswell Biotechnologies Enters Critical Phase of Industrializing Molecular Sensor Production
Premium

Jun 2, 2020

Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending
Premium

May 27, 2020

John Theurer Cancer Center, Genomic Testing Cooperative to Establish NGS Lab for Cancers

May 6, 2020

Pediatric Cancer Patients With Solid Tumors Have Many Druggable Germline Alterations

Nov 12, 2019

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

Jul 30, 2019

Illumina Says Population Sequencing, DTC Will Continue to Grow in the Long Term
Premium

Jul 23, 2019

BostonGene Partners With NIH on Clonal Evolution Study

Jul 12, 2019

Pathologists Face Hurdles in Supporting Precision Oncology, Seek Shared Decision Making
Premium

Apr 26, 2019

Inivata Clinical Validation Bolsters Liquid Biopsy Evidence Base, Aids Platform Comparisons
Premium

Apr 25, 2019

Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Oct 1, 2018

Caris Raises $150M in Debt, Convertible Note Financing

Jun 19, 2018

Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B

Apr 26, 2018

FDA Grants Breakthrough Device Designation to Foundation Medicine Liquid Biopsy Assay

Jan 31, 2018

Syapse Expands Into Asia With Korean Hospital Deal

Jan 30, 2018

Foundation Medicine to Profile Samples for European Cancer Network to Aid Clinical Trial Enrollment

Dec 4, 2017

UCSF, NantHealth Team on Metastatic Breast Cancer Study

Nov 15, 2017

FDA Approves MSKCC Tumor Profiling Test; Accredits NY State Health Department as IVD Reviewer

Nov 8, 2017

Caris Life Sciences Sues Foundation Medicine, Alleging Patent Infringement

Sep 20, 2017

Hearst Invests $75M in M2Gen

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.